RenovaCare Inc. (RCAR)

Overview

RenovaCare, Inc. is a development-stage biotech and medical device company engaged in the forefront of research, development, and the intended commercialization of innovative autologous cellular therapies. These advanced treatments are designed for medical and aesthetic applications, tapping into the body's natural healing mechanisms. Originally operating under the name Janus Resources, Inc., the company underwent a rebranding to RenovaCare, Inc. in January 2014, signaling a strategic pivot towards its current focus areas. With its headquarters established in Scottsdale, Arizona, RenovaCare aims to revolutionize patient care in tissue regeneration and recovery.

Products and Services

• CellMist System

This cutting-edge treatment methodology is at the heart of RenovaCare's innovative approach to regenerative medicine. The CellMist System is developed for the efficient isolation of human skin cells, aiming to enable the regeneration of damaged skin tissues. This technology targets a broad spectrum of medical conditions requiring skin repair and regeneration, potentially transforming the landscape of wound care and dermatological treatments.

• SkinGun

A complementary solution to the CellMist System, the SkinGun is a specially designed sprayer device that facilitates the precise and gentle application of isolated cells onto treatment areas. This device plays a crucial role in ensuring that the cellular material is delivered in an optimal state to support effective tissue regeneration. The SkinGun represents a significant advancement in the application technology of regenerative cell therapies, emphasizing ease of use and maximizing the potential for healing and aesthetic improvement.

• Strategic Collaboration with StemCell Systems GmbH

At the core of RenovaCare's strategic initiatives is its collaboration with StemCell Systems GmbH. This partnership focuses on enhancing the capabilities and effectiveness of RenovaCare's technologies through the isolation and spraying of self-donated stem cells. The ultimate goal of this collaboration is to expand the applications of RenovaCare's treatments beyond skin regeneration, potentially addressing the need for tissue and organ regeneration across a variety of medical conditions.